The medical black technology system of the top student

Not long after Pfizer's letter was posted online, the official account of the Institute of Drug Research immediately updated its news and announced the development of new targeted drugs.

This attitude couldn't be more obvious. Since Pfizer is unwilling to put the drug on the market, it should take matters into its own hands and develop new drugs.

This news undoubtedly lifted everyone's spirits.

After all, all Lu Liang's previous achievements were there, facing this similar and identical situation.

Therefore, most people are more willing to believe that Lu Liang can still succeed this time.

At the same time, in the office, Joey was listening to his subordinates reporting on the current news.

Currently, the China branch has sorted out the current situation and reported back. They said that they have now officially announced the development of a new targeted drug for pancreatic cancer.

And, it is said that they have already achieved considerable results in pancreatic cancer drugs.

After listening to his subordinate's report, Joey's expression did not change much.

After his subordinates left, the door of Joey's office was knocked again, and this time it was Cai Tao who walked in.

Cai Tao said, If you wish, they are already developing new targeted drugs for pancreatic cancer.

Joey said calmly: What's the hurry? This is just the beginning. Besides, targeted drugs for pancreatic cancer are not so easy to develop.

When he said this, a playful smile appeared on Joey's face: When our company developed this drug, there was a lot of luck in it, and it was finally successful.

For some reasons, the company has kept these results secret so far and has not published them.

Cai Tao frowned slightly: What do you mean?

Joey smiled slightly and then said: Let me tell you this, the real difficulty with targeted drugs for pancreatic cancer is not the drugs, but the targets.

In the Hengrui Pharmaceutical Company building.

Sun Piao was holding his mobile phone and looking at the situation on the Internet. After flipping through the news from the Institute of Drug Research, Sun Piao raised the corners of his mouth slightly.

Then he put down his phone as if on a whim, looked at Zhao Rui and said, Old Zhao, let me ask you something.

Zhao Rui looked at Sun Piao: Mr. Sun, tell me, what's the matter?

Sun Piao thought about it carefully: If, I mean if, if you were to lead our company's entire research team to develop a targeted drug against pancreatic cancer, how confident are you that you can develop a new drug?

After hearing Sun Piao's question, Zhao Rui suddenly showed a hesitant look on his face: It depends on the conditions.

Sun Piao thought for a moment: Suppose, no matter the cost, with the strong support of the company, how confident are you?

Zhao Rui thought for a long time, then gave a wry smile and gave his own answer: If you really want to invest regardless of the cost and let me do it, I will probably only be 20% sure.

After hearing Zhao Rui's answer, Sun Piao couldn't help but frowned: Only 20%?

Obviously, Sun Piao was very surprised by Zhao Rui's answer.

You know, Zhao Rui has been the leader of Hengrui's R\u0026D team over the years, and has developed many new drugs for Hengrui.

Therefore, in terms of technology, Sun Piao has always been quite confident in Zhao Rui.

But Zhao Rui was only less than 20% sure about the development of targeted drugs for pancreatic cancer, which somewhat surprised Sun Piao.

Zhao Rui shook his head and said: Mr. Sun, the 20% certainty is already very high.

Why?

Sun Piao expressed confusion. Hengrui Company had successfully developed various anti-cancer drugs.

Although the investment in research and development of anti-cancer drugs is indeed much higher than that of ordinary disease treatment drugs, as long as the investment is large enough and the support is strong enough, the possibility of success is still high.

Therefore, in Sun Piao's view, although pancreatic cancer is the king of cancers, a new targeted drug has been developed.

It shouldn't be much more difficult than other anti-cancer drugs, so why is the probability of success so low?

Zhao Rui also smiled bitterly and explained: Mr. Sun, pancreatic cancer cannot be compared with other cancers. Cancers such as lung cancer and liver cancer actually already have very clear and effective targets.

But pancreatic cancer is different. There are currently many known targets for pancreatic cancer, such as vegfr, egfr, motch, kras, etc., which are all targets of pancreatic cancer.

But the problem is that these targets are not very effective and cannot have a very good inhibitory effect on pancreatic cancer.

It can be said that so far, the medical community has still not been able to find a very effective target in the research of pancreatic cancer.

This is where it's really difficult to develop targeted drugs for pancreatic cancer.

This feeling is like, even if you have the ability to shoot arrows with perfect accuracy, the problem is that there is no clear target!

In this case, no matter how superb your archery ability is, it is still useless!

After listening to Zhao Rui's words, Sun Piao nodded silently. He seemed to have some understanding of why targeted drugs for pancreatic cancer are so difficult to develop.

Then, Sun Piao glanced at the screen of his mobile phone. He looked at the new notice from the Institute of Drug Research, and then asked: Old Zhao, how confident do you think he is?

Zhao Rui looked at the notice from the Institute of Drug Research and replied after a moment of silence: If it is him, I estimate that he should be at least 80% sure.

Sun Piao looked at Zhao Rui in astonishment: Why is it so high?

Zhao Rui sighed and said, Mr. Sun, look at the notice from the Institute of Drug Research. It says that 'certain results have been achieved'.

If nothing else happens, I estimate that the student from the Pharmaceutical University should have found a new target long ago, otherwise he would not be so confident.

Listening to Zhao Rui's words, Sun Piao nodded suddenly.

Afterwards, Sun Piao said with a smile: Tell me, it would have been great if we had raised the salary and recruited this student!

Hengrui Company actually sent an offer to Lu Liang a long time ago, but Lu Liang did not accept it at the time.

When Sun Piao said this, Zhao Rui couldn't help but clicked his tongue. If Lu Liang could really be recruited back then, and there was a person like Lu Liang in the company, then their Hengrui Pharmaceutical's status would be in jeopardy.

It doesn't take much to say that it can reach the world's first-class level and compete with those pharmaceutical giants.

That scene is so exciting just thinking about it!

It's just that you just have to think about this kind of thing. Sun Piao said with a smile.

Zhao Rui also nodded in agreement. After all, it can be seen from the other party's behavior that the two parties were not on the same page from the beginning.